Lederer & Associates Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Sell
5,291
-608
-10% -$208K 1.26% 25
2026
Q1
$2.08M Sell
5,899
-741
-11% -$264K 1.47% 23
2025
Q4
$2.17M Sell
6,640
-43
-0.6% -$13.6K 1.46% 19
2025
Q3
$1.89M Sell
6,683
-175
-3% -$50.8K 1.22% 25
2025
Q2
$1.92M Sell
6,858
-36
-0.5% -$10.2K 1.27% 23
2025
Q1
$2.15M Sell
6,894
-50
-0.7% -$14.8K 1.57% 18
2024
Q4
$1.81M Sell
6,944
-15
-0.2% -$4.45K 1.26% 23
2024
Q3
$2.24M Sell
6,959
-94
-1% -$30.7K 1.58% 15
2024
Q2
$2.2M Sell
7,053
-350
-5% -$103K 1.59% 15
2024
Q1
$2.1M Sell
7,403
-1,731
-19% -$507K 1.46% 19
2023
Q4
$2.63M Sell
9,134
-213
-2% -$58K 1.95% 12
2023
Q3
$2.51M Sell
9,347
-73
-0.8% -$18.2K 2% 10
2023
Q2
$2.09M Sell
9,420
-28
-0.3% -$6.5K 1.58% 17
2023
Q1
$2.28M Sell
9,448
-88
-0.9% -$21.6K 1.76% 14
2022
Q4
$2.5M Sell
9,536
-332
-3% -$89K 2.05% 10
2022
Q3
$2.22M Sell
9,868
-171
-2% -$41.5K 1.88% 12
2022
Q2
$2.44M Sell
10,039
-1,356
-12% -$332K 1.88% 11
2022
Q1
$2.76M Sell
11,395
-152
-1% -$34.9K 1.69% 16
2021
Q4
$2.6M Sell
11,547
-134
-1% -$28.3K 1.51% 20
2021
Q3
$2.48M Buy
11,681
+1,616
+16% +$372K 1.6% 22
2021
Q2
$2.45M Sell
10,065
-215
-2% -$52.9K 1.63% 21
2021
Q1
$2.56M Buy
10,280
+41
+0.4% +$9.78K 1.8% 17
2020
Q4
$2.35M Sell
10,239
-74
-0.7% -$17.1K 1.81% 19
2020
Q3
$2.62M Buy
10,313
+44
+0.4% +$10.9K 2.18% 8
2020
Q2
$2.42M Sell
10,269
-65
-0.6% -$14.8K 2.26% 12
2020
Q1
$2.1M Buy
10,334
+163
+2% +$35.6K 2.37% 11
2019
Q4
$2.45M Sell
10,171
-2,569
-20% -$566K 2.13% 11
2019
Q3
$2.46M Sell
12,740
-325
-2% -$62.4K 2.36% 10
2019
Q2
$2.41M Buy
13,065
+400
+3% +$71.6K 2.21% 8
2019
Q1
$2.41M Sell
12,665
-105
-0.8% -$20.1K 2.24% 9
2018
Q4
$2.49M Sell
12,770
-380
-3% -$74.1K 2.66% 5
2018
Q3
$2.73M Buy
13,150
+310
+2% +$61.1K 2.3% 8
2018
Q2
$2.37M Sell
12,840
-325
-2% -$57.5K 2.14% 9
2018
Q1
$2.24M Sell
13,165
-141
-1% -$25.9K 2.02% 10
2017
Q4
$2.31M Buy
13,306
+277
+2% +$49K 2.07% 14
2017
Q3
$2.43M Buy
13,029
+41
+0.3% +$7.26K 2.32% 8
2017
Q2
$2.24M Buy
12,988
+695
+6% +$113K 2.16% 10
2017
Q1
$2.02M Buy
12,293
+130
+1% +$21.6K 1.89% 17
2016
Q4
$1.78M Buy
+12,163
New +$1.83M 1.76% 25
2015
Q3
$1.54M Buy
+11,110
New +$1.75M 1.71% 25

Other funds holding AMGN

Lederer & Associates Investment Counsel's AMGN Position: Q2 2026 in Review

Lederer & Associates Investment Counsel reduced its Amgen (AMGN) stake by 10% in Q2 2026, selling an estimated $208K and leaving 5,291 shares worth $1.92M. The position accounts for 1.26% of the portfolio, ranked #25.

Lederer & Associates Investment Counsel first reported a position in AMGN in Q3 2015 and has held it in 40 quarters since. The position peaked at $2.76M in Q1 2022. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lederer & Associates Investment Counsel held 5,291 shares of Amgen worth $1.92M as of Q2 2026.
  • Lederer & Associates Investment Counsel sold 608 Amgen shares in Q2 2026, an estimated $208K.
  • Amgen made up 1.26% of Lederer & Associates Investment Counsel's portfolio in Q2 2026, its #25 holding.
  • Lederer & Associates Investment Counsel first reported a position in Amgen in Q3 2015 and has held it in 40 quarters since.
  • Lederer & Associates Investment Counsel's Amgen position peaked at $2.76M in Q1 2022.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2026, filed 10 Jul 2026.